UBS Maintains Buy on Aemetis, Raises Price Target to $3
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
UBS analyst Manav Gupta maintains Aemetis (NASDAQ:AMTX) with a Buy and raises the price target from $2.2 to $3.
UBS analyst Manav Gupta maintains Aemetis (NASDAQ:AMTX) with a Buy and raises the price target from $2.2 to $3.